LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
Scienture Holdings Inc.
Headquarters:
Lutz, FL, United States of America
Website:
https://scienture.com/
Year Founded:
2010
Status:
Public
Industry Sector:
CommercialServices
CEO:
Surendra Ajjarapu, MBA
Number Of Employees:
19
Enterprise Value:
$23,645,121
PE Ratio:
-0.08
Exchange/Ticker 1:
NASDAQ:SCNX
Exchange/Ticker 2:
N/A
Latest Market Cap:
$11,888,000
BioCentury
|
Apr 4, 2025
Data Byte
FDA’s six new product approvals in March
First drug for Prader-Willi hyperphagia, first Xolair biosimilar
Read More
BioCentury
|
Mar 14, 2025
Data Byte
Ten PDUFA dates on FDA’s March agenda
Upcoming decisions include a label expansion for Alnylam’s Amvuttra, a new siRNA therapy for hemophilia, and more
Read More
Items per page:
10
1 - 2 of 2